Figures 3E, F showed the expression levels of KIF2C, G6PD, CCNJL, CDC20, TRIP13, HAVCR1, MPP2, CEP55, IGLON5, SLC2A1, ALX1, TEX15, MSC, IGF2BP3, FGF9, OR8A1, RCOR2, PFN2, DDN, CLDN6, UGT1A10, ZNF280A, PRR20G, DNAJC5G, SLC16A3, BOLL, KRT17, DAW1, RFPL4B, RIPPLY2, UNC13C, RIMKLA, GABRA3, PLBD1, PRDM9, POU3F2, and FABP6 in HCC tissues. This evidence concerns the gene PRDM9 and hepatocellular carcinoma.